A trispecific antibody targeting HER2 and T cells inhibits breast cancer growth via CD4 cells February 2022 | Nature
Trispecific antibodies enhance the therapeutic efficacy of tumor-directed T cells through T cell receptor co-stimulation November 2019 | Nature Cancer
Rationale for Raising Current Clinical Practice Guideline Target for Serum 25-Hydroxyvitamin D in Chronic Kidney Disease March 2019 | PubMed
Extended-release calcifediol for secondary hyperparathyroidism in stage 3-4 chronic kidney disease September 2017 | PubMed
Trispecific broadly neutralizing HIV antibodies mediate potent SHIV protection in macaques September 2017 | Science
Use of Extended-Release Calcifediol to Treat Secondary Hyperparathyroidism in Stages 3 and 4 Chronic Kidney Disease September 2016 | PubMed